SEC Form 4 · accession 0001415889-15-003250
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas L Mayers
Officer — CHIEF MEDICAL OFFICER
Period of report
Oct 1, 2015
Accepted (ET)
Oct 2, 2015 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F2,F1 | $0.70 | Oct 1, 2015 | A | 2,400,000 | A | — | Oct 1, 2025 | Common Stock | 2,400,000 | 2,400,000 | D |
Explanation of responses
- F1The Securities vest in four equal annual increments with the first vesting date being one year from the Transaction Date.
- F2Not applicable